Home Archive Vol.40, No.3, 2014 Graves Disease in Albanian Children

Graves Disease in Albanian Children

Agim Gjikopulli(1), Sonila Tomori(1), L. Kollcaku(1), P. Hoxha(1), Lindita Grimci(1), Zamira Ylli(2)

(1)Division of Pediatric Endocrinology, Department of Pediatrics, University Hospital Centre “Mother Teresa”, Albania, (2)Department of Laboratory, University Hospital Centre “Mother Teresa”, Albania

    Abstract: Graves disease (GD) accounts for 10–15% of thyroid disorders in patients less than 18 years of age. It is the most common cause of thyrotoxicosis in children and accounts for at least 95% of cases in children. Pediatric Treatment of Graves’ disease consists of anti-thyroid drugs, radioactive iodide and thyroidectomy but the optimal treatment of GD in children is still controversial. Objective: To review treatment outcome of pediatric Graves’ disease in Albania. Material and Method: Descriptive review of 15 children with Graves’ disease, diagnosed from Jan.2007 to Dec. 2013, at the Division of Pediatric Endocrinology, Department of Pediatrics, University Hospital Centre “Mother Teresa”, Albania was performed. Results: All patients, mean age 10.56 ± 3.37 years, (range 2.02-16.09 years) were presented with goiter and increased serum FT4, mean 39.80 ± 16.02 ng/mL, (range 21.0-74.70 ng/mL), serum FT3, mean 12.98 ± 3.45 pg/mL, (range 6.90 -17.90 pg/mL) and suppressed TSH levels, mean 0.02 ± 0.01 mUI/L, (range 0.01-0.05 mUI/L). Anti TSH Receptor were positive in 100% of patients mean value 6.51 ± 3.61 UI/mL (range 1.63 – 14.10 UI/mL). Anti-thyroglobulin and Anti-TPO antibodies were positive in 60% and 46.6% respectively. Clinical course of 15 patients after treatment with anti-thyroid drugs mainly MMI for 3.19 ± 1.48 (range 0.60 - 6.20) years is as follows: seven (46.66%) underwent remission, five out of seven (71.41%) who underwent remission, relapsed. Three of them (20%) were treated with I131, and two (13.3%) underwent to total thyroidectomy. Conclusion: MMI was the most common first line therapy in the presented patients with Graves’ disease. Remission rate was 46.66% after an average 1.48 ± 0.71 years (range 0.60 – 2.70 years) of treatment with anti-thyroid drugs. Remission period was 2.70 ± 0.36 years (2.1 – 3.1 years) Relapse occurred in 71.41% of patient. I131 and thyroidectomy were used as second line therapy in the present study.
    Keywords: Graves disease, Antithyroid drugs, Remission, Relapse, Radioactive iodide, Thyroidectomy

DOI 10.12865/CHSJ.40.03.06


All articles in this issue

Volume 40 Issue 3 2014